Finland
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 1.34 B
|
Dec. 31, 2023 | USD 27.55 | -1.02% |
|
Finland |
|
2 |
USD 2.13 M
|
Dec. 31, 2023 | USD 3.51 | -13.37% |
|
Finland |
|
3 |
USD 917.70 K
|
Dec. 31, 2023 | USD 1.68 | 1.85% |
|
Finland |
|
4 |
USD -1.03 M
|
Dec. 31, 2023 | USD 8.76 | -1.71% |
|
Finland |
|
5 |
USD -19.48 M
|
Dec. 31, 2023 | USD 1.33 | 4.66% |
|
Finland |
|
6 |
USD -31.31 M
|
Dec. 31, 2023 | USD 2.50 | 2.59% |
|
Finland |
The Biotechnology company in Finland with the highest EBITDA is UPM-Kymmene Oyj (Helsinki Stock Exchange: UPM.HE) at USD 1.34 B.
The Biotechnology company in Finland with the lowest EBITDA is Faron Pharmaceuticals Oy (LSE: FARN.L) at USD -31.31 M.
The top 10 Biotechnology companies in Finland by EBITDA are UPM-Kymmene Oyj, Biohit Oyj, Herantis Pharma Oyj, Nexstim Plc, Nanoform Finland Oyj and Faron Pharmaceuticals Oy.
The bottom 10 Biotechnology companies in Finland by EBITDA are Faron Pharmaceuticals Oy, Nanoform Finland Oyj, Nexstim Plc, Herantis Pharma Oyj, Biohit Oyj and UPM-Kymmene Oyj.